RESEARCH TRIANGLE PARK – Precision Biosciences, Fathom Holdings and Tenax Therapeutics recently reported quarterly earnings. Here’s a recap:

  • Tenax Therapeutics

MORRISVILLE – Tenax Therapeutics Inc. (TENX) on Monday reported a loss of $23.7 million in its first quarter.

The Morrisville, North Carolina-based company said it had a loss of $1.64 per share.

In the final minutes of trading on Monday, the company’s shares hit $2.08. A year ago, they were trading at 98 cents.

  • Precision BioSciences

DURHAM – Precision BioSciences Inc. (DTIL) on Thursday reported a loss of $18.7 million in its first quarter.

The Durham, North Carolina-based company said it had a loss of 33 cents per share.

The results topped Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 49 cents per share.

The genome editing company posted revenue of $16.3 million in the period, which also topped Street forecasts. Three analysts surveyed by Zacks expected $8.8 million.

Precision BioSciences shares have risen 7% since the beginning of the year. The stock has increased 26% in the last 12 months.

  • Fathom Holdings

CARY – Fathom Holdings Inc. (FTHM) on Thursday reported a loss of $3.4 million in its first quarter.

On a per-share basis, the Cary, North Carolina-based company said it had a loss of 25 cents.

The company posted revenue of $49.6 million in the period.

Fathom Holdings shares have fallen 27% since the beginning of the year.